Jasper Therapeutics

JSPRNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$15.636 M

$0.47 -8.06%

Close of 6 Nov 2026

As of 6 Nov 2026, Jasper Therapeutics (JSPR) has a market capitalization of $15.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$75.80

Loss-making

Shares outstanding

33,274,561

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#140Estrella ImmunopharmaESLA$17.6M
#141PluriPLUR$17.1M
#142Jasper TherapeuticsJSPR$15.6M
#143Acumen PharmaceuticalsABOS$15.4M
#144Atyr PharmaATYR$15.4M

What if Jasper Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$848,602.46

Per share 1,805,921× higher

Bitcoin $1.53T

$45,916.40

Per share 97,715× higher

Apple $5.02T

$150,739.26

Per share 320,790× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Jasper Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.